Heather Davis
16Patents
8h-index
29Co-inventors
68Inventor score
Filing activity: Nov 4, 1996 → Oct 9, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6406705B1 | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant | Emerging Cross-Sectional Technologies | 386 | Expired |
| US6339068B1 | Vectors and methods for immunization or therapeutic protocols | Chemistry; Metallurgy | 281 | Expired |
| US5780448A | DNA-based vaccination of fish | Emerging Cross-Sectional Technologies | 159 | Expired |
| US7488490B2 | Method of inducing an antigen-specific immune response by administering a synergistic combination of adjuvants comprising unmethylated CpG-containing nucleic acids and a non-nucleic acid adjuvant | Emerging Cross-Sectional Technologies | 67 | Expired |
| US6821957B2 | Vectors and methods for immunization or therapeutic protocols | Chemistry; Metallurgy | 57 | Expired |
| US6180614A | DNA based vaccination of fish | Emerging Cross-Sectional Technologies | 31 | Expired |
| US7998492B2 | Methods and products related to treatment and prevention of hepatitis C virus infection | Human Necessities | 22 | Expired |
| US8202688B2 | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant | Emerging Cross-Sectional Technologies | 11 | Expired |
| US10456463B2 | Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules | Emerging Cross-Sectional Technologies | 8 | Active |
| US9205143B2 | Pneumococcal vaccine and uses thereof | Human Necessities | 6 | Active |
| US8980276B2 | Conjugates for the prevention or treatment of nicotine addiction | Emerging Cross-Sectional Technologies | 3 | Active |
| US8552165B2 | Immunostimulatory oligonucleotides | Emerging Cross-Sectional Technologies | 3 | Active |
| US8574599B1 | Methods and products for inducing mucosal immunity | Human Necessities | 2 | Expired |
| US6635624B1 | Nucleotide vector composition containing such vector and vaccine for immunization against hepatitis | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7825097B2 | Nucleotide vector vaccine for immunization against hepatitis | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9453059B2 | Immunostimulatory oligonucleotides | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.